A third mifepristone product has received a positive score for procurement by the Expert Review Panel (ERP). The mifepristone 200mg product is manufactured by Acme Formulation in India. Acme is one of the companies supported by Concept Foundation through our Access to Maternal Health programme. Acme’s misoprostol 200µg tablet was prequalified by the WHO Prequalification Team in April this year.
The ERP review product dossiers and provides recommendations on procurement to UNFPA for a temporary duration of 18 months for products that are under assessment for WHO prequalification. Further information can be found on products recommended for procurement on the UNFPA procurement page.